• UCLA Health
  • myUCLAhealth
  • School of Medicine
Center for Women's Pelvic Health

Center for Women's Pelvic Health at UCLA

Center for Women's Pelvic Health
  • About Us
    • Welcome
    • Contact Us
    • News & Media
    • Webinars & Videos
  • Conditions Treated
    • Pelvic Organ Prolapse
    • Fecal Incontinence
    • Neurogenic Bladder
    • Interstitial Cystitis/Bladder Pain Syndrome
    • Urinary Incontinence
    • Urinary Tract Infections (UTI)
    • Fistulas
    • Urethral Diverticulum
    • Urethral Stricture
    • Overactive Bladder
    • Postpartum Pelvic Floor Conditions
  • Urinary Incontinence & Overactive Bladder
    • What is Urinary Incontinence
    • Symptoms & Diagnosis
    • Treatment
    • Childbirth & Incontinence
    • Overactive Bladder
  • Diagnostic Testing & Office Services
    • Postpartum Pelvic Floor Health Program
    • Urodynamics
    • Botox for Overactive Bladder
    • Injections for Incontinence
    • PTNS
  • Patient Education
    • Childbirth & Incontinence
    • Pelvic Floor Disorders
    • Vaginal Rejuvenation Vs. Pelvic Floor Reconstruction
    • Uterine Prolapse Treatment Without Hysterectomy
  • Patient Information
    • Get an Expert Second Opinion
    • Contact Us & Locations
    • Your First Visit
    • Webinars & Videos
    • My UCLA Health
  • Training & Research
    • Education
    • Research
    • Clinical Trials
  • Expert Team
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

Center for Women's Pelvic Health at UCLA

Training & Research

Training & Research

Training & Research

  • Education
  • Research
  • Clinical Trials
  • Education
  • Research
  • Clinical Trials
  1. Home
  2. Training & Research
  3. Clinical Trials

Clinical Trials

Share this

Clinical Trials for the Center for Women’s Pelvic Health at UCLA

A clinical trial is a study conducted with actual patients, usually to evaluate a new treatment. Each study is designed to answer scientific questions and to find new and better ways to help patients.

Ongoing Clinical Trials for Female Pelvic Medicine and Reconstruction:

Effects of vaginal laser therapy on vaginal and urinary microbiota 

Official study title: Effect of microablative CO2 laser therapy on the vaginal and urinary bacterial and fungal microbiota of postmenopausal women with genitourinary syndrome of menopause 

Description: The purpose of this study is to confirm and better understand the effects of microablative CO2 laser therapy in treating symptoms and signs of genitourinary symptoms of menopause “GSM” and to study the effects of this treatment on the bacteria and fungi found in the bladder and vagina. We plan to accomplish this by asking women who have already chosen vaginal laser therapy as a clinical treatment for their GSM symptoms.

Basic information: Patients will receive laser therapy according to standard procedure for this treatment, receiving three treatments spaced 6 weeks apart, and follow-up appointments at 6 and 12 months. Patients will receive an exam, swabs, and be asked to take surveys. Patients must meet the following criteria:

    • Female
    • Post-menopausal
    • Reports symptoms of GSM (vaginal dryness, burning, or irritation; painful intercourse; urinary urgency; or recurrent UTI)
    • Elected treatment with laser therapy

For more information, visit UCLA Health Clinical Trials.

Principal Investigator:
Chad Z. Baxter, MD
Assistant Clinical Professor of UCLA Urology

Contact Information:
Email: [email protected]
Tel: 310-267-4331

ELITE-InterStim Micro System Post-Market Study

Official Study Title: Medtronic Evaluation of InterStim Micro System Performance And Safety (ELITE) to Confirm Long-Term Outcomes

Description: The purpose of this study is to gather long-term information on the use of the InterStim Micro System.

The information from this study will be used to:

  • Learn more about how use of the InterStim Micro System may impact patients’ symptoms
  • Learn more about how use of the InterStim Micro System may affect patients’ daily living

Symptoms of overactive bladder include an increased urge to urinate which may lead to unconscious leakage of urine and/or a frequent urination, symptoms of fecal incontinence include the inability to control bowel movements and symptoms for non-obstructive urinary retention include the inability to urinate.

The InterStim Micro System mentioned above is approved by the U.S. Food and Drug Administration (FDA), for patients who have overactive bladder, fecal incontinence and/or non-obstructive urinary retention. InterStim Therapy is for subjects for whom less invasive treatments have not worked.

Basic Information: We expect that participants will be in this research study for about 2 years.

Patients will have two surgeries to implant the InterStim Micro System and will be asked to come in for 7 study visits. You will be asked to fill out bladder and/or bowel diaries and questionnaires.

Patients must meet the following criteria:

  • Have a diagnosis of fecal incontinence or non-obstructive urinary retention
  • Candidate for sacral neuromodulation therapy in accordance with InterStim Micro System Labeling
  • 18 years of age or older
  • Willing and able to accurately complete study diaries, questionnaires, attend visits, device recharging, and comply with study protocol

For more information, visit UCLA Health Clinical Trials.

Principal Investigator:
Victor Nitti, MD
Professor of Urology and Obstetrics and Gynecology
Chief of Female Pelvic Medicine and Reconstructive Surgery (FPMRS)

Contact Information:
Email: [email protected]
Tel: 310-267-4331

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-800-UCLA-MD1
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth